Navigation Links
An analysis of the surgical and perioperative complications in right hepatectomies
Date:9/17/2008

Adult living related liver donors play an essential role in filling the gap of transplants needed due to a heavy shortage of cadaveric donations. Considering that living related donors are healthy individuals at baseline, it is imperative to ensure good outcomes and return to quality of life.

A research article to be published on 28 May 2008, in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Salvatore Gruttadauria from Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione designed an accurate, comprehensive step-by-step work-up protocol for donor evaluation to ensure donor safety and to confirm that the donor is capable of providing a suitable graft.

The strategy of careful evaluation of the living donor performed by an interdisciplinary team cannot be overemphasized. Their research has proven the necessity of evaluating the overall health of both the donor and recipient at many different levels from biopsy to body mass index. Their research has indicated liver biopsy in the exclusion of potential donors otherwise considered fit to donate. These biopsies assess the quality of the donation to ensure the likelihood of success of the transplant and the health of both the donor and the recipient.

Authors' experience shows that heavier donors, when subjected to an exercise and diet program, all return to previous activity. In fact, no life threatening complications, long term impairments, or deaths have occurred in these donors.

With all of this in mind, the study was designed to evaluate operative complications in a series of seventy five patients. In heir series, 30.6% of living donors developed a complication in the perioperative period. Complications related to biliary tree reconstruction (9.33%) were the most common, although no patients had to undergo repeated open surgery. None of the 75 live donors in the series, regardless of their post-operative course,
'/>"/>

Contact: Lai-Fu Li
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Advanced blood analysis may speed diagnosis of heart attacks
2. San Francisco Bay Area Cell Analysis Company Forges Partnership With Hudson Control Group as First Step in Automation Initiative to Support Drug Discovery Research
3. ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
4. Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
5. Kansas Health Policy Authority Awards Thomson Reuters Contract for Health Care Data Integration and Analysis Initiative
6. Next generation data analysis for next generation sequencing data
7. Analysis of cancer incidence, mortality and survival combined reveals encouraging European trends
8. Caris Diagnostics Providing KRAS Mutational Analysis for Colon Cancer Patients
9. The DataTrace(R) RF System, the Latest High Performance Radio Data Logger for Real-Time, Process Data Collection, Reporting, and Analysis Is Launched
10. Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance
11. Analysis of Millions of U.S. Births Shows Association Between Birth Defects and Preterm Birth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...rathiomolybdate (TM) has been shown in studies to ... disease caused by an overload of copper, and cert...ittle, however, is known about how the drug works ...thwestern University researchers now has provided ...e of TM bound to copper-loaded metallochaperones. ...
(Date:11/26/2009)...letters from the North Pole, Textsanta.net lets pa...Santa , North Pole, AK (P...ciencies at the North Pole Santa Claus has added S...he globe informed of his Christmas progress at the...epartment have identified a large and growing perc...
(Date:11/26/2009)...ommunications announces a highly effective and unc...truggling to make an economic recovery. , ...fears is the type of challenge that could send ail... to Dr. David Benton, business growth expert and a... – The Rfactor Intensive . “Fear is...
(Date:11/25/2009)...wswire/--TheBartleHallConventionCenterwilltemporar...,whenKansasCityhoststhelatestinaseriesofmassivefre...venthasthepotentialtobethebiggestoneyet,becauseitw...kdaysinsteadofoveraweekend,"SheriWood,executivedir...theNationalAssociationofFreeClinics(NAFC). ,, A...
(Date:11/25/2009)...-SentinelleMedicalInc.,aleadingmanufacturerofbreas...suiteofnewleadingedgeclinicalapplicationsonitsAegi...iologicalSocietyofNorthAmerica(RSNA)annualmeetingi...licationsleveragetheuniquehighqualityimagesgenerat...rtmultipleimagingmodalitiesformulti-parametricasse...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...ce some unique health issues , , MINNEAPOLIS/ST. ...xpected to go to school this fall as a result of t...ll need to ensure student veterans, unique needs a...iversities (MnSCU). , , The report, "Health and ...
...e and Washington DC (May 29, 2009) The FDA is igno...pprove an over-the-counter, rapid HIV test for hom...l Medical Decision Making ( MDM ) which is publi...ord it. The FDA has been criticized because it ba...
...s availability of alerts on pharmaceutical compani...The alerts include recent news, trading activity a...l of the daily stock alerts for free by visiti...sdaq: PPHM ), Biogen Idec Inc. (Nasdaq: BIIB )...
... risks may outweigh benefits, research suggests ,...g aspirin reduces heart attack risk in people with...ases the risk of internal bleeding, say British re...risks may cancel each other out. However, the rese...
...xpanding Ocular Pharmaceuticals Portfolio and Offe...ar Bacterial Pathogens(1) - , , , MADISON, N.J.,...health, today announced that the U.S. Food and Dru...rred to as "pink eye." Besivance(TM) is a new t...
...mp; Development will be one of the presenters at D...ention of new devices in interventional gastroente...(PRWEB) May 29, 2009 -- Zeus, Inc., a leader in po..., Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specia...
Other Medicine News:Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3Health News:FDA ignores critical information on home HIV tests 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 2Health News:Beacon Equity Issues Stock Alerts on Leading Pharmaceutical Giants 3Health News:Value of Taking Aspirin to Cut Heart Risk Varies 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 3Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 4Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 5Health News:Zeus to Present at Digestive Disease Week in Chicago 2
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 1Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 2Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research 26 Development 13756 3avVaa World Health Care Products Inc Announces the completion of its first week of DRTV 120 60 second test commercials for Neuroskin 28R 29 Psoriasi 13755 1avVaa World Health Care Products Inc Announces the completion of its first week of DRTV 120 60 second test commercials for Neuroskin 28R 29 Psoriasi 13755 2Syncope and implantable loop recorders 3A Good value for money 3F 55818 1Syncope and implantable loop recorders 3A Good value for money 3F 55818 2Syncope and implantable loop recorders 3A Good value for money 3F 55818 3
... ARNHEM, The Netherlands, April 16 The European...deration the recent,scientific information on rand...¶der et al, NEJM 2009). Based on the results of th...ate Cancer (ERSPC), the EAU has formulated a,posit...in Europe, and the,subsequent actions to be taken ...
...nly 39 Percent of Newly Diagnosed Patients Receive...According to a New Report from Decision Resources ...Decision Resources, one of the world,s leading res...l and healthcare issues, finds that surveyed neuro...eir use of emerging oral agents --- Merck Serono,s...
Other Medicine Technology:EAU Position Statement on Screening for Prostate Cancer 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 2Surveyed Neurologists Anticipate That Less Than 30 Percent of Their Use of Emerging Oral Agents in Multiple Sclerosis Will be in the First Line 3
5 mm and 10 mm Laparoscopy Instrument Repair and Reinsulation
...er optics reduce the light output to your surgical...ptical clarity that is so vital. Frequent inspecti...l to prevent further damage and more extensive and...echnician can inspect your cables for you at no ch...
Rigid Endoscope Repair
...inspects your equipment upon arrival. Our technici...ovides you with a thorough customer quote. We resp...so well help you prioritize repairs. With customer... , ISI uses only OEM or widely approved equivale...
Medicine Products: